Clinical Trial Update: Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treatment of metastatic castration-resistant prostate cancer using circulating tumor cell kinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: UNICANCER | Conditions: Prostate Carcinoma, Castration-resistant Prostate Cancer | Phase 2 | Status: COMPLETED